BSX vs. PODD: Boston Scientific vs. Insulet Stock Comparison

November 11, 2026

How do Boston Scientific (BSX) and Insulet (PODD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Boston Scientific (BSX) and Insulet (PODD) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Company profile comparison for Boston Scientific (BSX) and Insulet (PODD)
Profile Item	BSX	PODD
Name	Boston Scientific Corp.	Insulet Corporation
Country/Region	United States	United States
GICS Sector	Health Care	Health Care
GICS Industry Group	Health Care Equipment & Services	Health Care Equipment & Services
GICS Industry	Health Care Equipment & Supplies	Health Care Equipment & Supplies
GICS Sub-Industry	Health Care Equipment	Health Care Equipment
Market Capitalization	61.96 billion USD	10.16 billion USD
Currency	USD	USD
Exchange	NYSE	Nasdaq
Listing Date	May 19, 1992	May 15, 2007
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

BSX

PODD

GSPC

Boston Scientific (BSX) vs. Insulet (PODD), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Boston Scientific (BSX) and Insulet (PODD). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Boston Scientific (BSX) and Insulet (PODD). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Boston Scientific (BSX) and Insulet (PODD)
Metric	BSX	PODD
Total Return (1Y)	-55.98%	-53.25%
Total Return (3Y, Annualized)	-5.05%	-0.74%
Total Return (5Y, Annualized)	0.57%	-14.02%

Risk Profile

Drawdown History

BSX

PODD

GSPC

Boston Scientific (BSX) vs. Insulet (PODD), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Boston Scientific (BSX) and Insulet (PODD). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Boston Scientific (BSX) and Insulet (PODD)
Metric	BSX	PODD
Volatility (1Y, Annualized)	40.16%	46.33%
Beta (5Y)	0.57	1.04
Max Drawdown (5Y)	-61.55%	-63.02%
Avg. Volume (3M)	19.73M	1.58M

Risk-Adjusted Performance

Risk-Return Positioning

BSX and PODD are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Boston Scientific (BSX) and Insulet (PODD)
Metric	BSX	PODD
Sharpe Ratio (1Y)	-1.50	-1.24
Sortino Ratio (1Y)	-1.80	-1.51

Profitability

ROE (TTM)

Insulet (PODD) at 28.94% sits in the top ROE quartile, while Boston Scientific (BSX) at 14.12% is closer to the peer norm — stronger capital efficiency for PODD.

BSX

Health Care Equipment & Services industry group

14.12%

Max: 47.61%
Q3: 14.36%
BSX: 14.12%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

PODD

Health Care Equipment & Services industry group

28.94%

Max: 47.61%
PODD: 28.94%
Q3: 14.36%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

Boston Scientific (BSX) vs. Insulet (PODD): A comparison of their ROE against the Health Care Equipment & Services industry group benchmark.

Net Margin (TTM)

For every dollar of sales, both Boston Scientific (BSX) at 16.62% and Insulet (PODD) at 13.44% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

BSX

Health Care Equipment & Services industry group

16.62%

Max: 29.35%
BSX: 16.62%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

PODD

Health Care Equipment & Services industry group

13.44%

Max: 29.35%
PODD: 13.44%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

Boston Scientific (BSX) vs. Insulet (PODD): A comparison of their net margin against the Health Care Equipment & Services industry group benchmark.

Operating Margin (TTM)

Both Boston Scientific (BSX) at 19.05% and Insulet (PODD) at 22.54% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

BSX

Health Care Equipment & Services industry group

19.05%

Max: 35.43%
BSX: 19.05%
Q3: 14.14%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

PODD

Health Care Equipment & Services industry group

22.54%

Max: 35.43%
PODD: 22.54%
Q3: 14.14%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

Boston Scientific (BSX) vs. Insulet (PODD): A comparison of their operating margin against the Health Care Equipment & Services industry group benchmark.

Profitability Metrics

Profitability metrics for Boston Scientific (BSX) and Insulet (PODD)
Metric	BSX	PODD
ROE (TTM)	14.12%	28.94%
ROA (TTM)	5.87%	11.40%
Net Margin (TTM)	16.62%	13.44%
Operating Margin (TTM)	19.05%	22.54%
Gross Margin (TTM)	67.98%	71.88%

Growth

Revenue Growth

Insulet (PODD) at 30.73% sits in the top revenue growth quartile, while Boston Scientific (BSX) at 19.87% is closer to the peer norm — faster top-line expansion for PODD.

Boston Scientific (BSX) vs. Insulet (PODD): A comparison of their Revenue Growth across different time periods.

EPS Growth

Boston Scientific (BSX) at 55.20% sits in the top EPS growth quartile, while Insulet (PODD) at -39.79% is in the bottom quartile, showing a clear gap in earnings momentum.

Boston Scientific (BSX) vs. Insulet (PODD): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Boston Scientific (BSX) and Insulet (PODD)
Metric	BSX	PODD
Revenue Growth (YoY)	19.87%	30.73%
Revenue Growth (3Y CAGR)	16.54%	27.54%
EPS Growth (YoY)	55.20%	-39.79%
EPS Growth (3Y CAGR)	62.75%	267.70%

Financial Strength

Current Ratio (MRQ)

Insulet (PODD) at 2.51 keeps current ratio within its industry’s typical mid-range, while Boston Scientific (BSX) at 1.37 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for BSX.

BSX

Health Care Equipment & Services industry group

1.37

Max: 7.59
Q3: 4.00
Median: 1.98
Q1: 1.37
BSX: 1.37
Min: 0.30

PODD

Health Care Equipment & Services industry group

2.51

Max: 7.59
Q3: 4.00
PODD: 2.51
Median: 1.98
Q1: 1.37
Min: 0.30

Boston Scientific (BSX) vs. Insulet (PODD): A comparison of their current ratio against the Health Care Equipment & Services industry group benchmark.

Debt / Equity (MRQ)

Both Boston Scientific (BSX) at 0.46 and Insulet (PODD) at 0.66 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

BSX

Health Care Equipment & Services industry group

0.46

Max: 1.88
Q3: 0.91
Median: 0.58
BSX: 0.46
Q1: 0.16
Min: 0.00

PODD

Health Care Equipment & Services industry group

0.66

Max: 1.88
Q3: 0.91
PODD: 0.66
Median: 0.58
Q1: 0.16
Min: 0.00

Boston Scientific (BSX) vs. Insulet (PODD): A comparison of their debt-to-equity ratio against the Health Care Equipment & Services industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Boston Scientific (BSX) and Insulet (PODD)
Metric	BSX	PODD
Current Ratio (MRQ)	1.37	2.51
Debt / Equity (MRQ)	0.46	0.66
Net Debt / EBITDA	2.04	0.65

Dividends

Dividend Yield (TTM)

Neither Boston Scientific (BSX) nor Insulet (PODD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

BSX

Health Care Equipment & Services industry group

0.00%

BSX: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PODD

Health Care Equipment & Services industry group

0.00%

PODD: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Boston Scientific (BSX) vs. Insulet (PODD): A comparison of their dividend yield against the Health Care Equipment & Services industry group benchmark.

Dividend Payout Ratio (TTM)

Neither Boston Scientific (BSX) nor Insulet (PODD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

BSX

Health Care Equipment & Services industry group

0.00%

BSX: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PODD

Health Care Equipment & Services industry group

0.00%

PODD: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Boston Scientific (BSX) vs. Insulet (PODD): A comparison of their payout ratio against the Health Care Equipment & Services industry group benchmark.

Dividend Metrics

Dividend metrics for Boston Scientific (BSX) and Insulet (PODD)
Metric	BSX	PODD
Dividend Yield (TTM)	0.00%	0.00%
Dividend Payout Ratio (TTM)	0.00%	0.00%

Valuation

P/E Ratio (TTM)

Boston Scientific (BSX) at 18.04 sits in the cheaper P/E ratio quartile, while Insulet (PODD) at 23.94 is closer to its industry’s usual earnings multiple — a discount for BSX, though growth and earnings durability still matter.

BSX

Health Care Equipment & Services industry group

18.04

Max: 80.41
Q3: 47.62
Median: 29.93
Q1: 21.19
BSX: 18.04
Min: 4.21

PODD

Health Care Equipment & Services industry group

23.94

Max: 80.41
Q3: 47.62
Median: 29.93
PODD: 23.94
Q1: 21.19
Min: 4.21

Boston Scientific (BSX) vs. Insulet (PODD): A comparison of their P/E ratio against the Health Care Equipment & Services industry group benchmark.

P/S Ratio (TTM)

On P/S ratio, both Boston Scientific (BSX) at 2.94 and Insulet (PODD) at 3.19 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

BSX

Health Care Equipment & Services industry group

2.94

Max: 8.80
Q3: 4.32
BSX: 2.94
Median: 2.13
Q1: 1.10
Min: 0.03

PODD

Health Care Equipment & Services industry group

3.19

Max: 8.80
Q3: 4.32
PODD: 3.19
Median: 2.13
Q1: 1.10
Min: 0.03

Boston Scientific (BSX) vs. Insulet (PODD): A comparison of their P/S ratio against the Health Care Equipment & Services industry group benchmark.

P/B Ratio (MRQ)

Boston Scientific (BSX) at 2.42 is valued about in line with its industry on P/B ratio, while Insulet (PODD) at 6.44 carries an above-peer premium to book — PODD is pricier on assets.

BSX

Health Care Equipment & Services industry group

2.42

Max: 11.68
Q3: 6.12
Median: 3.00
BSX: 2.42
Q1: 1.73
Min: -1.31

PODD

Health Care Equipment & Services industry group

6.44

Max: 11.68
PODD: 6.44
Q3: 6.12
Median: 3.00
Q1: 1.73
Min: -1.31

Boston Scientific (BSX) vs. Insulet (PODD): A comparison of their P/B ratio against the Health Care Equipment & Services industry group benchmark.

Valuation Metrics

Valuation metrics for Boston Scientific (BSX) and Insulet (PODD)
Metric	BSX	PODD
P/E Ratio (TTM)	18.04	23.94
P/S Ratio (TTM)	2.94	3.19
P/B Ratio (MRQ)	2.42	6.44
Free Cash Flow Yield (TTM)	4.02%	1.12%